Vortioxetine improves symptomatic and functional outcomes in major depressive disorder: A novel dual outcome measure in depressive disorders
Journal of Affective Disorders Nov 21, 2017
Christensen MC, et al. - This research was designed to assess the combined effect of vortioxetine on depressive symptoms and functional capacity in adults with major depressive disorder (MDD). Vortioxetine showed a robust combined effect on depressive symptoms and functional capacity in patients with MDD, but no effect was found with duloxetine.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty -
Paid Market Research Surveys -
Case discussions, News & Journals' summaries
